| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | -4.8% |
| Cost of Revenue | $1.5M | +5.3% |
| Gross Profit | $566K | -23.8% |
| R&D Expense | $1.9M | -39.4% |
| SG&A Expense | $7.0M | +62.1% |
| Operating Income | -$8.3M | +19.1% |
| Interest Expense | $23K | +5.3% |
| Pre-tax Income | -$8.2M | +21.5% |
| Net Income | -$8.2M | +21.5% |
| EPS (Basic) | -$2.58 | -160.6% |
| EPS (Diluted) | -$2.58 | -160.6% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | +6.1% |
| Accounts Receivable | $118K | +60.3% |
| Inventory | $118K | -44.4% |
| Current Assets | $5.0M | +4.1% |
| Total Assets | $7.5M | +1.0% |
| Current Liabilities | $784K | -20.2% |
| Total Liabilities | $868K | -16.6% |
| Stockholders' Equity |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -11.0% |
| Capital Expenditures | $5K | -94.2% |
| Investing Cash Flow | -$5K | +94.2% |
| Financing Cash Flow | $5.4M | -36.7% |
| Free Cash Flow | -$5.1M | -8.9% |
| $6.7M |
| +3.9% |